• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型5-(萘基磺酰基)-2,4-噻唑烷二酮的合成及其降血糖活性

Synthesis and antihyperglycemic activity of novel 5-(naphthalenylsulfonyl)-2,4-thiazolidinediones.

作者信息

Zask A, Jirkovsky I, Nowicki J W, McCaleb M L

机构信息

Medicinal Chemistry Department, Wyeth-Ayerst Research, Princeton, New Jersey 08543-8000.

出版信息

J Med Chem. 1990 May;33(5):1418-23. doi: 10.1021/jm00167a022.

DOI:10.1021/jm00167a022
PMID:2329563
Abstract

A series of 5-(naphthalenylsulfonyl)-2,4-thiazolidinediones were synthesized and evaluated for antihyperglycemic activity in an insulin-resistant, genetically diabetic db/db mouse model of non-insulin-dependent diabetes mellitus (NIDDM). The sulfones could be synthesized by a novel, selective C-5 sulfonylation of dilithio-2,4-thiazolidinedione with appropriate sulfonyl chlorides. Within this series, naphthalene was found to be superior to other groups for eliciting antihyperglycemic activity, including the p-alkoxyphenyl group found in ciglitazone, a prototypical agent for this activity. Attachment of the 5-sulfonyl-2,4-thiazolidinedione moiety to the 2-naphthalene position led to optimum activity. Other linkers between the naphthalene and 2,4-thiazolidinedione rings, such as thio, methylene, oxy, and sulfinyl led to decreased antihyperglycemic activity. The best analogue, 5-(2-naphthalenylsulfonyl)-2,4-thiazolidinedione (AY-31,637) was equipotent to ciglitazone in two animal models of NIDDM.

摘要

合成了一系列5-(萘基磺酰基)-2,4-噻唑烷二酮,并在非胰岛素依赖型糖尿病(NIDDM)的胰岛素抵抗、遗传性糖尿病db/db小鼠模型中评估其降血糖活性。这些砜类化合物可通过二锂化-2,4-噻唑烷二酮与适当的磺酰氯进行新型选择性C-5磺酰化反应来合成。在该系列化合物中,发现萘基在引发降血糖活性方面优于其他基团,包括在具有该活性的典型药物环格列酮中发现的对烷氧基苯基。将5-磺酰基-2,4-噻唑烷二酮部分连接到2-萘位可产生最佳活性。萘环与2,4-噻唑烷二酮环之间的其他连接基,如硫代、亚甲基、氧基和亚磺酰基,会导致降血糖活性降低。最佳类似物5-(2-萘基磺酰基)-2,4-噻唑烷二酮(AY-31,637)在两种NIDDM动物模型中的效力与环格列酮相当。

相似文献

1
Synthesis and antihyperglycemic activity of novel 5-(naphthalenylsulfonyl)-2,4-thiazolidinediones.新型5-(萘基磺酰基)-2,4-噻唑烷二酮的合成及其降血糖活性
J Med Chem. 1990 May;33(5):1418-23. doi: 10.1021/jm00167a022.
2
Antihyperglycemic activity of novel substituted 3H-1,2,3,5-oxathiadiazole 2-oxides.新型取代的3H-1,2,3,5-氧杂二氮唑-2-氧化物的降血糖活性
J Med Chem. 1992 Apr 3;35(7):1176-83. doi: 10.1021/jm00085a002.
3
Novel benzoxazole 2,4-thiazolidinediones as potent hypoglycemic agents. Synthesis and structure-activity relationships.
Chem Pharm Bull (Tokyo). 1997 Dec;45(12):1984-93. doi: 10.1248/cpb.45.1984.
4
Actions of novel antidiabetic thiazolidinedione, T-174, in animal models of non-insulin-dependent diabetes mellitus (NIDDM) and in cultured muscle cells.新型抗糖尿病噻唑烷二酮类药物T-174在非胰岛素依赖型糖尿病(NIDDM)动物模型及培养的肌肉细胞中的作用。
Br J Pharmacol. 1998 Oct;125(3):429-36. doi: 10.1038/sj.bjp.0702066.
5
Studies on antidiabetic agents. IV. Synthesis and activity of the metabolites of 5-[4-(1-methylcyclohexylmethoxy)benzyl]-2,4-thiazolidinedione (ciglitazone).抗糖尿病药物研究。IV. 5-[4-(1-甲基环己基甲氧基)苄基]-2,4-噻唑烷二酮(环格列酮)代谢产物的合成与活性
Chem Pharm Bull (Tokyo). 1984 Jun;32(6):2267-78. doi: 10.1248/cpb.32.2267.
6
Novel spirosuccinimides with incorporated isoindolone and benzisothiazole 1,1-dioxide moieties as aldose reductase inhibitors and antihyperglycemic agents.具有异吲哚酮和苯并异噻唑1,1 - 二氧化物部分的新型螺琥珀酰亚胺类化合物作为醛糖还原酶抑制剂和抗高血糖药物。
J Med Chem. 1992 Nov 27;35(24):4613-27. doi: 10.1021/jm00102a016.
7
Synthesis and biological activity of metabolites of the antidiabetic, antihyperglycemic agent pioglitazone.
J Med Chem. 1996 Dec 20;39(26):5053-63. doi: 10.1021/jm9605694.
8
Antihyperglycemic activity of new 1,2,4-oxadiazolidine-3,5-diones.
Eur J Med Chem. 2001 Jan;36(1):31-42. doi: 10.1016/s0223-5234(00)01191-0.
9
Antihyperglycemic activity of novel naphthalenyl 3H-1,2,3,5-oxathiadiazole 2-oxides.新型萘基3H-1,2,3,5-氧杂二唑2-氧化物的降血糖活性
J Med Chem. 1993 Aug 20;36(17):2485-93. doi: 10.1021/jm00069a006.
10
Novel euglycemic and hypolipidemic agents. 1.新型正常血糖和降血脂药物。1.
J Med Chem. 1998 May 7;41(10):1619-30. doi: 10.1021/jm970444e.

引用本文的文献

1
Sulfur fluoride exchange with carbon pronucleophiles.硫氟化物与碳亲核试剂的交换
Chem Sci. 2025 Aug 15. doi: 10.1039/d5sc03893f.
2
First-in-class inhibitors of Nsp15 endoribonuclease of SARS-CoV-2: Modeling, synthesis, and enzymatic assay of thiazolidinedione and rhodanine analogs.新型冠状病毒Nsp15核糖核酸酶的首创性抑制剂:噻唑烷二酮和若丹宁类似物的建模、合成及酶活性测定
J Biol Chem. 2025 Jun 23;301(8):110409. doi: 10.1016/j.jbc.2025.110409.
3
Testing the ability of rhodanine and 2, 4-thiazolidinedione to interact with the human pancreatic alpha-amylase: electron-density descriptors complement molecular docking, QM, and QM/MM dynamics calculations.
检测若丹宁和2,4-噻唑烷二酮与人类胰腺α-淀粉酶相互作用的能力:电子密度描述符补充分子对接、量子力学和量子力学/分子力学动力学计算。
J Mol Model. 2017 Sep;23(9):252. doi: 10.1007/s00894-017-3418-5. Epub 2017 Aug 5.
4
Synthesis and biological activity evaluation of 5-pyrazoline substituted 4-thiazolidinones.5-吡唑啉取代 4-噻唑烷酮的合成及生物活性评价。
Eur J Med Chem. 2013 Aug;66:228-37. doi: 10.1016/j.ejmech.2013.05.044. Epub 2013 Jun 6.